Latest Regulatory Oversight News

Superloop has reached a significant milestone under its exclusive Origin Energy contract, surpassing 250,000 broadband subscribers and triggering a share issuance obligation.

The ASX has suspended trading in eight companies for failing to lodge their periodic reports on time, raising fresh questions about compliance and market confidence.

Australian Bond Exchange Holdings Limited (ABE) has had its trading suspension lifted immediately following a capital raising announcement, signaling renewed investor engagement.

Orion Minerals has locked in a US$250 million prepayment facility with Glencore to fund key developments at its Prieska Copper Zinc Project, marking a pivotal step toward production in South Africa.

Aruma Resources Limited has had its AAJOA securities suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

The Federal Court of Australia has approved key restructuring schemes for Global Uranium and Enrichment Limited, paving the way for streamlined shareholder arrangements and regulatory exemptions in multiple jurisdictions.

DTI Group Ltd has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information behind the market activity.

Star Minerals has secured court orders confirming the legitimacy of its auditor changes and share issuance notices, resolving prior compliance issues and lifting its ASX trading suspension.

Peppermint Innovation Ltd has raised A$500,000 to accelerate the rollout of its bizmoto digital wallet platform across the Philippine cooperative sector, targeting millions of members and aiming to boost transaction frequency and recurring revenue.

Thorney Technologies Limited (ASX, TEK) will resume trading on the ASX from 16 December 2025 following the lodgement of its Net Tangible Asset Backing, ending its recent suspension.

Entropy Neurodynamics has successfully completed dosing the first patient in its TRP-8803 clinical trial for Binge Eating Disorder, marking a key milestone with controlled psychedelic infusion and safety clearance. Top-line results are expected in early 2026.

The Australian Treasurer has approved Hanwha Corporation’s increase of its direct equity stake in Austal Limited from 9.9% to 19.9%, setting the stage for potential strategic partnerships as Austal rides a wave of record revenues and defence contracts.